Ra Capital Management Now Owns 16.10% of DICE Therapeutics (DICE)

Fintel reports that Ra Capital Management has filed a 13D/A form with the SEC disclosing ownership of 7.66MM shares of DICE Therapeutics Inc (DICE). This represents 16.1% of the company.

admin